Literature DB >> 10648929

Analysis of cloned Fvs from a phage display library indicates that DNA immunization can mimic antibody response generated by cell immunizations.

P S Chowdhury1, I Pastan.   

Abstract

BACKGROUND: Generation and cloning of antibodies against cell surface antigens can be simplified by combining DNA immunization which enables generation of antibodies against a protein in its natural configuration without the need for any protein purification step and antibody phage display which due to its immense screening power and physical coupling between the phenotype and genotype of antibodies simplifies the cloning of antibody genes.
OBJECTIVES: Since DNA immunization is expected to elicit antibodies against a protein in its natural configuration, we wanted to see if it can mimic the antibody response generated by cell immunization. STUDY
DESIGN: A phage display library made from splenic mRNA of a mouse immunized with mesothelin cDNA was panned on mesothelin-positive cells. The single-chain Fvs (scFvs) selected were then analyzed.
RESULTS: We obtained several anti-mesothelin scFvs. One of these Fvs is almost identical to the Fv of a monoclonal antibody that was previously obtained from a hybridoma in which the mice were immunized with a mesothelin-positive ovarian cancer cell line. Another Fv was found to be specific for mesothelin present on human cells.
CONCLUSION: Our results indicate that an antibody phage display library made from spleens of DNA-immunized mice is a rapid and efficient alternative to cell immunization for obtaining antibodies against different epitopes of a membrane antigen that is very difficult to purify in a native form.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10648929     DOI: 10.1016/s0022-1759(99)00142-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Development and characterization of a monoclonal antibody against the putative T cells of Labeo rohita.

Authors:  Sanjay C Rebello; Gaurav Rathore; Peyush Punia; Neeraj Sood
Journal:  Cytotechnology       Date:  2015-03-07       Impact factor: 2.058

2.  Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy.

Authors:  Chien-Fu Hung; Xuequn Xu; Linhong Li; Ying Ma; Qiu Jin; Angelia Viley; Cornell Allen; Pachai Natarajan; Rama Shivakumar; Madhusudan V Peshwa; Leisha A Emens
Journal:  Hum Gene Ther       Date:  2018-04-02       Impact factor: 5.695

3.  A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity.

Authors:  Yang Feng; Xiaodong Xiao; Zhongyu Zhu; Emily Streaker; Mitchell Ho; Ira Pastan; Dimiter S Dimitrov
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

4.  Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Authors:  Raffit Hassan; Wolfgang Ebel; Eric L Routhier; Rina Patel; J Bradford Kline; Jingli Zhang; Qimin Chao; Sara Jacob; Howard Turchin; Lester Gibbs; Martin D Phillips; Shiyama Mudali; Christine Iacobuzio-Donahue; Elizabeth M Jaffee; Maria Moreno; Ira Pastan; Philip M Sass; Nicholas C Nicolaides; Luigi Grasso
Journal:  Cancer Immun       Date:  2007-12-19

5.  Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.

Authors:  Chien-Tsun Kuan; Nidhi Srivastava; Roger E McLendon; Wayne A Marasco; Michael R Zalutsky; Darell D Bigner
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

6.  Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents.

Authors:  Mahdi Shabani; Sheyda Hemmati; Reza Hadavi; Zahra Amirghofran; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2010-07

7.  Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.

Authors:  Emmanuel Zervos; Steven Agle; Andrew G Freistaedter; Gwendolyn J B Jones; Rachel L Roper
Journal:  J Exp Clin Cancer Res       Date:  2016-03-01

8.  Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Authors:  Mohamed A Alfaleh; Christopher B Howard; Ilya Sedliarou; Martina L Jones; Reema Gudhka; Natasha Vanegas; Jocelyn Weiss; Julia H Suurbach; Christopher J de Bakker; Michael R Milne; Bree A Rumballe; Jennifer A MacDiarmid; Himanshu Brahmbhatt; Stephen M Mahler
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

9.  Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.

Authors:  Michael White; Andrew Freistaedter; Gwendolyn J B Jones; Emmanuel Zervos; Rachel L Roper
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.